Citius Oncology, Inc.

CTOR · NASDAQ
Analyze with AI
$1.07−$0.065 (−5.75%)
At close:Dec 15, 2025, 8:59 PM UTC
$1.07+$0.005 (+0.47%)
After hours:Dec 16, 2025, 1:39 PM UTC
P/E TTM-2.87
P/B TTM2.35
P/S TTM0
Dividend Yield0%
EPS-$0.39
Beta2.991
Valuation
PEG Ratio1.06
FCF Yield0.00%
EV / EBITDA-3.69
More On Valuation »
Quality
ROIC-68.21%
Gross Margin0.00%
Cash Conv. Ratio-0.00
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth-710.52%
More On Growth »
Safety
Net Debt / EBITDA-0.15
Interest Coverage-158.50
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00
More On Efficiency »

Citius Oncology, Inc. (CTOR) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Citius Oncology, Inc. (CTOR) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, Citius Oncology, Inc. (CTOR) stock is trading at $1.07. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CTOR stock quotes for informed trading decisions.

What is Citius Oncology, Inc.'s market capitalization?

Citius Oncology, Inc. (CTOR) has a market capitalization of approximately $90.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Citius Oncology, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CTOR stock price changes.

What is the 52-week range for Citius Oncology, Inc. stock?

Citius Oncology, Inc. (CTOR) stock has traded in a 52-week range of $0.551 — $6.19. The 52-week range shows the highest and lowest prices at which CTOR traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Citius Oncology, Inc. stock price to this range provides context for recent price action.

How much trading volume does Citius Oncology, Inc. stock have?

Citius Oncology, Inc. (CTOR) stock recently traded approximately 414.4K shares. Trading volume indicates market liquidity and investor interest in CTOR. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Citius Oncology, Inc. stock.

Does Citius Oncology, Inc. pay dividends to shareholders?

Yes, Citius Oncology, Inc. (CTOR) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Citius Oncology, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Citius Oncology, Inc.'s intraday price range?

Today, Citius Oncology, Inc. (CTOR) stock has traded in a range of $1.03 — $1.17. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CTOR's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Citius Oncology, Inc. stock data?

AlphaPilot sources real-time CTOR stock quotes, fundamental financial data, and historical price charts for Citius Oncology, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Citius Oncology, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CTOR stock performance.